Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer
作者
Stephanie L. Wethington,Payal D. Shah,Lainie P. Martin,János L. Tanyi,Nawar Latif,Mark A. Morgan,Drew A. Torigian,Diego Rodriguez,Simon A. Smith,Emma Dean,Susan M. Domchek,Ronny Drapkin,Ie‐Ming Shih,Eric J. Brown,Wei‐Ting Hwang,Deborah K. Armstrong,Stéphanie Gaillard,Robert Giuntoli,Fiona Simpkins
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
嘻嘻哈哈
完美巧凡
渡人舟
GingerF
Oracle
Yeyiii
归零者
arniu2008
猪猪hero
你嵙这个期刊没买
369ninja
文LL
行走的荷尔蒙
soilman
xiaolizi
YifanWang
Nole
愉快的真
皖公网安备34019202002308
